4.3: Frequency and prescription pattern of AEDs among participants
The frequency of participants on medication were 604(64.2%) with those on monotherapy and polytherapy respectively been 498(52.9%) and 106(11.2%) respectively. The frequency of participants that were on CAP, LVC, Gabapentin, Valproate, Phenytoin, Clonazepam, Phenobarbiturate, CAP+LVC respectively were 414(68.5%), 56(9.2%), 1(0.1%), 11(1.8%), 11(1.8%), 1(0.1%), 4(0.6%), 55(9.1%) respectively. The mean (SD) of the participant on medication, monotherapy, polytherapy, CAP, LVC, Gabapentin, Valproate, Phenytoin, Clonazepam, Phenobarbiturate, CAP+LVC respectively were 44.43(10.48), 44.08(10.65), 46.10(9.52), 44.26(10.59), 44.63(10.58), 65, 37.91(13.40), 38.91(9.44), 36, 45.50(3.00), 47.44(8.61) respectively. (See Table 3)
4.4 Frequency of reported adverse effects of PWE.
The highest reported ADR in PWE were nervousness (34.3%), aggression (33.6%) and weight gain (32.3%). Specifically, (20.1%) of the participant complained of memory problem, while the lowest were hair loss (7.2%), trouble with mouth or gum (8.9%) and problem with skin (9.3%). (see Table 4)